pioglitazone hydrochloride

FDA Drug Profile — PIOGLITAZONE HYDROCHLORIDE

pioglitazone hydrochloride is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand name including PIOGLITAZONE HYDROCHLORIDE. Available dosage forms: tablet, powder.

Drug details

Generic Name
pioglitazone hydrochloride
Brand Names
PIOGLITAZONE HYDROCHLORIDE
Application Number
ANDA200268
Sponsor
A-S Medication Solutions
NDC Codes
17
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
PIOGLITAZONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Monotherapy and Combination Therapy Pioglitazone Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] . Important Limitations of Use Pioglitazone Tablets exerts its antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone Tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions (5.3) ] . Pioglitazone Tablets is a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. ( 1, 14) Important Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.